JAISIM SHAH

CIK 1242133 · See Remarks · last filed 2024-12-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.3K

Companies

3

Total Filings

29

Lifetime Open-Market Net

-$670.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCLXW See Remarks 295,215 $0.17 $50.2K $197.2K 8 2024-12-18
SRNE Director 178,075 $0.00 $89 $399.7K 16 2021-08-30
PDL BIOPHARMA, INC. (PDLI) Delisted SVP, Mktg & Bus. Affairs 15,812 -$1.27M 5 2008-04-30

Recent Filings · Page 3 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-09-22 SRNE Grant (A) $0 EDGAR
2013-11-26 SRNE Buy (P) +1,000 $8.7K EDGAR
2013-11-20 SRNE Buy (P) +1,000 $9.0K EDGAR
2013-10-31 SRNE Grant (A) $0 EDGAR
2008-04-30 PDL BIOPHARMA, INC. (PDLI) Delisted Exer (M) +1,251 $10.7K EDGAR
2007-08-17 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) $0 EDGAR
2007-04-30 PDL BIOPHARMA, INC. (PDLI) Delisted Mixed +260 -$168.4K EDGAR
2007-04-24 PDL BIOPHARMA, INC. (PDLI) Delisted Mixed -$160.2K EDGAR
2007-04-17 PDL BIOPHARMA, INC. (PDLI) Delisted Mixed -$293.8K EDGAR
Showing 2129 of 29
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.